Corton Capital’s Definium Therapeutics DFTX Stock Holding History

Corton Capital’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-14,416	Closed	-$100K	–	318
2024 Q4	$100K	Buy	+14,416	New	+$99.2K	0.06%	350

Other funds holding DFTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Corton Capital's DFTX Position: Q1 2025 in Review

Corton Capital sold out of Definium Therapeutics (DFTX) in Q1 2025, closing a stake of 14,416 shares — an estimated $100K sold.

Corton Capital first reported a position in DFTX in Q4 2024 and held it in 1 quarter. The position peaked at $100K in Q4 2024. 190 funds tracked by Wall St. Rank hold DFTX as of Q1 2025.

Corton Capital reported no remaining Definium Therapeutics position as of Q1 2025 after selling out during the quarter.
Corton Capital sold 14,416 Definium Therapeutics shares in Q1 2025, an estimated $100K.
Corton Capital first reported a position in Definium Therapeutics in Q4 2024 and held it in 1 quarter.
Corton Capital's Definium Therapeutics position peaked at $100K in Q4 2024.
190 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2025.

Based on Corton Capital's 13F filing for Q1 2025, filed 7 May 2025.